Proponents of including delta-8 tetrahydrocannabinol among the ingredients considered hemp in the US won’t be encouraged by the findings of a pharma industry consultant who also has studied allowing cannabis sales for medical purposes.
Other cannabis derivatives that some businesses may attempt to sell as meeting the statutory definition for hemp – any part of the cannabis plant containing no more than 0.3% delta-9...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?